Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to sections 13 or 15(d)

STOCK WARRANTS (Details Textual) (USD $)	6 Months Ended
STOCK WARRANTS (Details Textual) (USD $)	Jun. 30, 2012
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares)	275,000
Warrants Exercise Price (in dollars per share)	$ 1.00
Warrant Expiration Maximum Period	5 years
Warrants Issued During Period To Purchase Common Stock	7,390,292
January 2012 Financing [Member] \| Placement Agents [Member]
Warrants Issued During Period To Purchase Common Stock	235,295
March 2012 Financing [Member] \| Placement Agents [Member]
Warrants Issued During Period To Purchase Common Stock	231,482
Financing Arrangements [Member] \| Placement Agents [Member]
Warrants Issued During Period To Purchase Common Stock	466,777
Placement Agents [Member]
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares)	30,750
Warrants Exercise Price (in dollars per share)	$ 1.25
Warrant Expiration Maximum Period	7 years
January 2012 Financing [Member]
Warrants Issued During Period To Purchase Common Stock	4,302,950
March 2012 Financing [Member]
Warrants Issued During Period To Purchase Common Stock	2,314,815
Financing Arrangements [Member]
Warrants Exercise Price (in dollars per share)	$ 1.25
Warrant Expiration Maximum Period	5 years